Crystal structure of human small C-terminal domain phosphatase 1 (Scp1) bound to rabeprazoleCrystal structure of human small C-terminal domain phosphatase 1 (Scp1) bound to rabeprazole

Structural highlights

3pgl is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:,
Gene:CTDSP1, CTDSP1 or SCP1, NIF3, NLIIF, SCP1 (Homo sapiens)
Activity:Phosphoprotein phosphatase, with EC number 3.1.3.16
Resources:FirstGlance, OCA, RCSB, PDBsum

Publication Abstract from PubMed

The unstructured C-terminal domain (CTD) of eukaryotic RNA polymerase II dynamically regulates the process of transcription by recruiting different factors to nascent mRNA through its multiple phosphorylation patterns. A newly discovered class of phosphatases, the human small C-terminal domain phosphatases (Scp's), specifically dephosphorylates phosphorylated Ser(5) (phospho.Ser(5)) of the tandem heptad repeats of the CTD of RNA polymerase II. Scp's also function as transcription regulators that epigenetically silence the expression of specific neuronal genes, whose inactivation leads to neuronal stem cell differentiation. Small molecule inhibitors of Scp's will be valuable for elucidating their mechanism in nervous system development and can possibly offer new strategies to treat diseases related to neurodegeneration. Despite the difficulty in developing selective inhibitors of protein phosphatases, we have recognized a characteristic hydrophobic binding pocket adjacent to the active site in Scp's that may facilitate selective inhibition. In the present study, we successfully identified the first selective lead compound, rabeprazole, for the Scp/TFIIF-interacting CTD phosphatase (Fcp) family. The high-resolution crystal structure of rabeprazole-bound Scp1 showed that the compound indeed binds to the hydrophobic binding pocket. We further confirmed that rabeprazole only targets Scp's but not its close family members Fcp1 and Dullard or bacteriophage lambda Ser/Thr phosphatase. Such specificity may prove important for In Vivo studies since accidental inhibition of Fcp1 or Dullard would result in cell malfunctions and even cell death.

Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule Inhibitor.,Zhang M, Cho EJ, Burstein G, Siegel D, Zhang Y ACS Chem Biol. 2011 Feb 24. PMID:21348431[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Zhang M, Cho EJ, Burstein G, Siegel D, Zhang Y. Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule Inhibitor. ACS Chem Biol. 2011 Feb 24. PMID:21348431 doi:10.1021/cb100357t

3pgl, resolution 2.35Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA